Literature DB >> 20638439

Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.

Christian Brabant1, Livia Alleva, Etienne Quertemont, Ezio Tirelli.   

Abstract

Neurons that produce histamine are exclusively located in the tuberomamillary nucleus of the posterior hypothalamus and send widespread projections to almost all brain areas. Neuronal histamine is involved in many physiological and behavioral functions such as arousal, feeding behavior and learning. Although conflicting data have been published, several studies have also demonstrated a role of histamine in the psychomotor and rewarding effects of addictive drugs. Pharmacological and brain lesion experiments initially led to the proposition that the histaminergic system exerts an inhibitory influence on drug reward processes, opposed to that of the dopaminergic system. The purpose of this review is to summarize the relevant literature on this topic and to discuss whether the inhibitory function of histamine on drug reward is supported by current evidence from published results. Research conducted during the past decade demonstrated that the ability of many antihistaminic drugs to potentiate addiction-related behaviors essentially results from non-specific effects and does not constitute a valid argument in support of an inhibitory function of histamine on reward processes. The reviewed findings also indicate that histamine can either stimulate or inhibit the dopamine mesolimbic system through distinct neuronal mechanisms involving different histamine receptors. Finally, the hypothesis that the histaminergic system plays an inhibitory role on drug reward appears to be essentially supported by place conditioning studies that focused on morphine reward. The present review suggests that the development of drugs capable of activating the histaminergic system may offer promising therapeutic tools for the treatment of opioid dependence.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638439     DOI: 10.1016/j.pneurobio.2010.07.002

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  19 in total

Review 1.  Proposed model of the neurobiological mechanisms underlying psychosocial alcohol interventions: the example of motivational interviewing.

Authors:  Sarah W Feldstein Ewing; Francesca M Filbey; Christian S Hendershot; Amber D McEachern; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2011-11       Impact factor: 2.582

Review 2.  Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

Authors:  Karen L Teff; Sangwon F Kim
Journal:  Physiol Behav       Date:  2011-06-12

3.  Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice.

Authors:  Saara Nuutinen; Minnamaija Lintunen; Jenni Vanhanen; Tiia Ojala; Stanislav Rozov; Pertti Panula
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

4.  Wireless fast-scan cyclic voltammetry measurement of histamine using WINCS--a proof-of-principle study.

Authors:  Su-Youne Chang; Taylor Jay; Joel Muñoz; Inyong Kim; Kendall H Lee
Journal:  Analyst       Date:  2012-03-14       Impact factor: 4.616

5.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Metabolomics of Neurotransmitters and Related Metabolites in Post-Mortem Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain.

Authors:  Mohammed Abul Kashem; Selina Ahmed; Nilufa Sultana; Eakhlas U Ahmed; Russell Pickford; Caroline Rae; Omar Šerý; Iain S McGregor; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2016-01-22       Impact factor: 3.996

Review 7.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

8.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

9.  The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.

Authors:  Maximiliano Rapanelli; Luciana R Frick; Kyla D Horn; Rivka C Schwarcz; Vladimir Pogorelov; Angus C Nairn; Christopher Pittenger
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

10.  Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.

Authors:  Edward D Levin; Brandon J Hall; Autri Chattopadhyay; Susan Slade; Corinne Wells; Amir H Rezvani; Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2016-06-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.